VIRTICI LLC

Address

720 BROADWAY
SEATTLE, WA, 98122-4302

http://www.virtici.com

Information

DUNS: 079131782
# of Employees: 6

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A Novel Tolerance Therapeutic for Treating Multiple Sclerosis

    Amount: $1,000,000.00

    Our goal is to develop VTC MS as a novel tolerance inducing therapeutic to treat Multiple Sclerosis MS MS is the most common demyelinating disorder of the Central Nervous System CNS affecting a ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. A Novel Peptide Therapeutic for Obesity

    Amount: $1,000,985.00

    Project Summary The goal of this project is to develop a novel peptide therapeutic VTC G for the treatment of obesity Today one third of adults in the United States US are obese with an estim ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  3. A Novel Tolerance Therapeutic for Treating Multiple Sclerosis

    Amount: $479,708.00

    DESCRIPTION provided by applicant Our goal is to develop VTC MS as a novel tolerance inducing therapeutic to treat Multiple Sclerosis MS MS is the most common demyelinating disorder of the Cent ...

    SBIRPhase I2016Department of Health and Human Services
  4. A Novel Probiotic for the Treatment of Sjogren's Syndrome

    Amount: $225,000.00

    Project Summary Our goal is to develop a novel L lactis probiotic based therapeutic for the treatment of Sj grenandapos s Syndrome SjS SjS is a progressive chronic autoimmune disease characterize ...

    SBIRPhase I2016Department of Health and Human Services
  5. A Novel Tolerance Therapeutic for Treating Peanut Allergy

    Amount: $318,728.00

    DESCRIPTION provided by applicant Our goal is to develop VTC as a novel tolerance inducing therapeutic to treat peanut allergy Peanut allergy is one of the most common and potentially fatal f ...

    SBIRPhase I2015Department of Health and Human Services
  6. A Novel Therapeutic Peptide for Treating Stroke

    Amount: $434,135.00

    DESCRIPTION provided by applicant Our goal is to develop a novel peptide therapeutic to alleviate brain and vascular injury after hemorrhagic and ischemic stroke Vascular injury is a leading cause ...

    SBIRPhase I2015Department of Health and Human Services
  7. XHA-A Novel Tolerance Therapeutic for Allergic Rhinitis

    Amount: $417,336.00

    DESCRIPTION (provided by applicant): The goal of this project is to extend the development of a novel compound that can reprogram memory T lymphocytes to induce tolerance in allergic rhinitis (AR). A ...

    SBIRPhase I2014Department of Health and Human Services
  8. A Novel Peptide Therapeutic for Obesity

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): The goal of this project is to develop a novel peptide therapeutic, GLP-1-5, for the treatment of obesity. Today, one-third of adults in the United States (US) are ...

    SBIRPhase I2014Department of Health and Human Services
  9. A Rapid, Blood RNA Assay for the Diagnosis of Acute Respiratory Infections

    Amount: $150,000.00

    DESCRIPTION (provided by applicant): Acute respiratory infections (ARIs) represent a major cause of morbidity and mortality in the world1. About 20% of all deaths in children younger than 5 years of a ...

    SBIRPhase I2013Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government